282727-24-6 Usage
Uses
Used in Liquid Crystal Display Industry:
BIPHENYL-3,4'-DICARBOXYLIC ACID 3-ISOPROPYL ESTER is used as an intermediate in the production of liquid crystal materials for its ability to form liquid crystalline phases, which are essential in the manufacturing of liquid crystal displays (LCDs).
Used in Pharmaceutical Industry:
BIPHENYL-3,4'-DICARBOXYLIC ACID 3-ISOPROPYL ESTER is used as an intermediate in the production of pharmaceuticals, where it may contribute to the development of new drugs or improve the synthesis of existing ones.
Used in Organic Synthesis:
BIPHENYL-3,4'-DICARBOXYLIC ACID 3-ISOPROPYL ESTER is used as a raw material in the synthesis of organic compounds, enabling the creation of new chemical entities with potential applications in various fields.
Used in Polymer Production:
BIPHENYL-3,4'-DICARBOXYLIC ACID 3-ISOPROPYL ESTER is used as a raw material in the production of polymers, where it may contribute to the development of advanced materials with unique properties.
Used in Medicine and Biological Research:
BIPHENYL-3,4'-DICARBOXYLIC ACID 3-ISOPROPYL ESTER may have potential applications in the field of medicine and biological research due to its unique properties, which could be explored for the development of new therapeutic agents or diagnostic tools.
Check Digit Verification of cas no
The CAS Registry Mumber 282727-24-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,8,2,7,2 and 7 respectively; the second part has 2 digits, 2 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 282727-24:
(8*2)+(7*8)+(6*2)+(5*7)+(4*2)+(3*7)+(2*2)+(1*4)=156
156 % 10 = 6
So 282727-24-6 is a valid CAS Registry Number.
282727-24-6Relevant articles and documents
COMPOUNDS AND METHODS
-
, (2008/06/13)
This invention relates to substituted benzanilides which are modulators, agonists or antagonists, of the CCR5 receptor. In addition, this invention relates to the treatment and prevention of disease states mediated by CCR5, including, but not limited to,